 | • レポートコード：MRC2-11QY11058 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はバイオバーデン試験のグローバル市場について調査・分析したレポートです。種類別（機器、消耗品）市場規模、用途別（製薬、バイオ技術、CMO）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別バイオバーデン試験の競争状況、市場シェア ・世界のバイオバーデン試験市場：種類別市場規模 2015年-2020年（機器、消耗品） ・世界のバイオバーデン試験市場：種類別市場規模予測 2021年-2026年（機器、消耗品） ・世界のバイオバーデン試験市場：用途別市場規模 2015年-2020年（製薬、バイオ技術、CMO） ・世界のバイオバーデン試験市場：用途別市場規模予測 2021年-2026年（製薬、バイオ技術、CMO） ・北米のバイオバーデン試験市場分析：米国、カナダ ・ヨーロッパのバイオバーデン試験市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのバイオバーデン試験市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のバイオバーデン試験市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのバイオバーデン試験市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Charles River Laboratories International、Sigma-Aldrich、SGS、Wuxi Pharmatech (CAYMAN)、Merck、Becton Dickinson、North American Science Associates Inc.、Nelson Laboratories、Pacific Biolabs、ATS Labs ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices.
Market Analysis and Insights: Global Bioburden Testing Market
The global Bioburden Testing market size is projected to reach US$ 598 million by 2026, from US$ 555.7 million in 2020, at a CAGR of 7.0%% during 2021-2026.
Global Bioburden Testing Scope and Market Size
Bioburden Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bioburden Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Charles River Laboratories International
Sigma-Aldrich
SGS
Wuxi Pharmatech (CAYMAN)
Merck
Becton Dickinson
North American Science Associates Inc.
Nelson Laboratories
Pacific Biolabs
ATS Labs
Market segment by Type, the product can be split into
Instruments
Consumables
Market segment by Application, split into
Pharmaceutical
Biotechnology
CMO
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bioburden Testing Revenue
1.4 Market by Type
1.4.1 Global Bioburden Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instruments
1.4.3 Consumables
1.5 Market by Application
1.5.1 Global Bioburden Testing Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical
1.5.3 Biotechnology
1.5.4 CMO
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bioburden Testing Market Perspective (2015-2026)
2.2 Global Bioburden Testing Growth Trends by Regions
2.2.1 Bioburden Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bioburden Testing Historic Market Share by Regions (2015-2020)
2.2.3 Bioburden Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bioburden Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Bioburden Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bioburden Testing Players by Market Size
3.1.1 Global Top Bioburden Testing Players by Revenue (2015-2020)
3.1.2 Global Bioburden Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Bioburden Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bioburden Testing Market Concentration Ratio
3.2.1 Global Bioburden Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bioburden Testing Revenue in 2019
3.3 Bioburden Testing Key Players Head office and Area Served
3.4 Key Players Bioburden Testing Product Solution and Service
3.5 Date of Enter into Bioburden Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bioburden Testing Historic Market Size by Type (2015-2020)
4.2 Global Bioburden Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bioburden Testing Market Size by Application (2015-2020)
5.2 Global Bioburden Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bioburden Testing Market Size (2015-2020)
6.2 Bioburden Testing Key Players in North America (2019-2020)
6.3 North America Bioburden Testing Market Size by Type (2015-2020)
6.4 North America Bioburden Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bioburden Testing Market Size (2015-2020)
7.2 Bioburden Testing Key Players in Europe (2019-2020)
7.3 Europe Bioburden Testing Market Size by Type (2015-2020)
7.4 Europe Bioburden Testing Market Size by Application (2015-2020)
8 China
8.1 China Bioburden Testing Market Size (2015-2020)
8.2 Bioburden Testing Key Players in China (2019-2020)
8.3 China Bioburden Testing Market Size by Type (2015-2020)
8.4 China Bioburden Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bioburden Testing Market Size (2015-2020)
9.2 Bioburden Testing Key Players in Japan (2019-2020)
9.3 Japan Bioburden Testing Market Size by Type (2015-2020)
9.4 Japan Bioburden Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bioburden Testing Market Size (2015-2020)
10.2 Bioburden Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bioburden Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Bioburden Testing Market Size by Application (2015-2020)
11 India
11.1 India Bioburden Testing Market Size (2015-2020)
11.2 Bioburden Testing Key Players in India (2019-2020)
11.3 India Bioburden Testing Market Size by Type (2015-2020)
11.4 India Bioburden Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bioburden Testing Market Size (2015-2020)
12.2 Bioburden Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Bioburden Testing Market Size by Type (2015-2020)
12.4 Central & South America Bioburden Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Charles River Laboratories International
13.1.1 Charles River Laboratories International Company Details
13.1.2 Charles River Laboratories International Business Overview
13.1.3 Charles River Laboratories International Bioburden Testing Introduction
13.1.4 Charles River Laboratories International Revenue in Bioburden Testing Business (2015-2020))
13.1.5 Charles River Laboratories International Recent Development
13.2 Sigma-Aldrich
13.2.1 Sigma-Aldrich Company Details
13.2.2 Sigma-Aldrich Business Overview
13.2.3 Sigma-Aldrich Bioburden Testing Introduction
13.2.4 Sigma-Aldrich Revenue in Bioburden Testing Business (2015-2020)
13.2.5 Sigma-Aldrich Recent Development
13.3 SGS
13.3.1 SGS Company Details
13.3.2 SGS Business Overview
13.3.3 SGS Bioburden Testing Introduction
13.3.4 SGS Revenue in Bioburden Testing Business (2015-2020)
13.3.5 SGS Recent Development
13.4 Wuxi Pharmatech (CAYMAN)
13.4.1 Wuxi Pharmatech (CAYMAN) Company Details
13.4.2 Wuxi Pharmatech (CAYMAN) Business Overview
13.4.3 Wuxi Pharmatech (CAYMAN) Bioburden Testing Introduction
13.4.4 Wuxi Pharmatech (CAYMAN) Revenue in Bioburden Testing Business (2015-2020)
13.4.5 Wuxi Pharmatech (CAYMAN) Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Bioburden Testing Introduction
13.5.4 Merck Revenue in Bioburden Testing Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Becton Dickinson
13.6.1 Becton Dickinson Company Details
13.6.2 Becton Dickinson Business Overview
13.6.3 Becton Dickinson Bioburden Testing Introduction
13.6.4 Becton Dickinson Revenue in Bioburden Testing Business (2015-2020)
13.6.5 Becton Dickinson Recent Development
13.7 North American Science Associates Inc.
13.7.1 North American Science Associates Inc. Company Details
13.7.2 North American Science Associates Inc. Business Overview
13.7.3 North American Science Associates Inc. Bioburden Testing Introduction
13.7.4 North American Science Associates Inc. Revenue in Bioburden Testing Business (2015-2020)
13.7.5 North American Science Associates Inc. Recent Development
13.8 Nelson Laboratories
13.8.1 Nelson Laboratories Company Details
13.8.2 Nelson Laboratories Business Overview
13.8.3 Nelson Laboratories Bioburden Testing Introduction
13.8.4 Nelson Laboratories Revenue in Bioburden Testing Business (2015-2020)
13.8.5 Nelson Laboratories Recent Development
13.9 Pacific Biolabs
13.9.1 Pacific Biolabs Company Details
13.9.2 Pacific Biolabs Business Overview
13.9.3 Pacific Biolabs Bioburden Testing Introduction
13.9.4 Pacific Biolabs Revenue in Bioburden Testing Business (2015-2020)
13.9.5 Pacific Biolabs Recent Development
13.10 ATS Labs
13.10.1 ATS Labs Company Details
13.10.2 ATS Labs Business Overview
13.10.3 ATS Labs Bioburden Testing Introduction
13.10.4 ATS Labs Revenue in Bioburden Testing Business (2015-2020)
13.10.5 ATS Labs Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bioburden Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Bioburden Testing Revenue
Table 3. Ranking of Global Top Bioburden Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bioburden Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Instruments
Table 6. Key Players of Consumables
Table 7. Global Bioburden Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Bioburden Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Bioburden Testing Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Bioburden Testing Market Share by Regions (2015-2020)
Table 11. Global Bioburden Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Bioburden Testing Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Bioburden Testing Market Growth Strategy
Table 17. Main Points Interviewed from Key Bioburden Testing Players
Table 18. Global Bioburden Testing Revenue by Players (2015-2020) (Million US$)
Table 19. Global Bioburden Testing Market Share by Players (2015-2020)
Table 20. Global Top Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioburden Testing as of 2019)
Table 21. Global Bioburden Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bioburden Testing Product Solution and Service
Table 24. Date of Enter into Bioburden Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 27. Global Bioburden Testing Market Size Share by Type (2015-2020)
Table 28. Global Bioburden Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Bioburden Testing Market Size Share by Application (2015-2020)
Table 30. Global Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 31. Global Bioburden Testing Market Size Share by Application (2021-2026)
Table 32. North America Key Players Bioburden Testing Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Bioburden Testing Market Share (2019-2020)
Table 34. North America Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 35. North America Bioburden Testing Market Share by Type (2015-2020)
Table 36. North America Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 37. North America Bioburden Testing Market Share by Application (2015-2020)
Table 38. Europe Key Players Bioburden Testing Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Bioburden Testing Market Share (2019-2020)
Table 40. Europe Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Bioburden Testing Market Share by Type (2015-2020)
Table 42. Europe Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Bioburden Testing Market Share by Application (2015-2020)
Table 44. China Key Players Bioburden Testing Revenue (2019-2020) (Million US$)
Table 45. China Key Players Bioburden Testing Market Share (2019-2020)
Table 46. China Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 47. China Bioburden Testing Market Share by Type (2015-2020)
Table 48. China Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 49. China Bioburden Testing Market Share by Application (2015-2020)
Table 50. Japan Key Players Bioburden Testing Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Bioburden Testing Market Share (2019-2020)
Table 52. Japan Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Bioburden Testing Market Share by Type (2015-2020)
Table 54. Japan Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Bioburden Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Bioburden Testing Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Bioburden Testing Market Share (2019-2020)
Table 58. Southeast Asia Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Bioburden Testing Market Share by Type (2015-2020)
Table 60. Southeast Asia Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Bioburden Testing Market Share by Application (2015-2020)
Table 62. India Key Players Bioburden Testing Revenue (2019-2020) (Million US$)
Table 63. India Key Players Bioburden Testing Market Share (2019-2020)
Table 64. India Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 65. India Bioburden Testing Market Share by Type (2015-2020)
Table 66. India Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 67. India Bioburden Testing Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Bioburden Testing Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Bioburden Testing Market Share (2019-2020)
Table 70. Central & South America Bioburden Testing Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Bioburden Testing Market Share by Type (2015-2020)
Table 72. Central & South America Bioburden Testing Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Bioburden Testing Market Share by Application (2015-2020)
Table 74. Charles River Laboratories International Company Details
Table 75. Charles River Laboratories International Business Overview
Table 76. Charles River Laboratories International Product
Table 77. Charles River Laboratories International Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 78. Charles River Laboratories International Recent Development
Table 79. Sigma-Aldrich Company Details
Table 80. Sigma-Aldrich Business Overview
Table 81. Sigma-Aldrich Product
Table 82. Sigma-Aldrich Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 83. Sigma-Aldrich Recent Development
Table 84. SGS Company Details
Table 85. SGS Business Overview
Table 86. SGS Product
Table 87. SGS Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 88. SGS Recent Development
Table 89. Wuxi Pharmatech (CAYMAN) Company Details
Table 90. Wuxi Pharmatech (CAYMAN) Business Overview
Table 91. Wuxi Pharmatech (CAYMAN) Product
Table 92. Wuxi Pharmatech (CAYMAN) Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 93. Wuxi Pharmatech (CAYMAN) Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Product
Table 97. Merck Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 98. Merck Recent Development
Table 99. Becton Dickinson Company Details
Table 100. Becton Dickinson Business Overview
Table 101. Becton Dickinson Product
Table 102. Becton Dickinson Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 103. Becton Dickinson Recent Development
Table 104. North American Science Associates Inc. Company Details
Table 105. North American Science Associates Inc. Business Overview
Table 106. North American Science Associates Inc. Product
Table 107. North American Science Associates Inc. Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 108. North American Science Associates Inc. Recent Development
Table 109. Nelson Laboratories Business Overview
Table 110. Nelson Laboratories Product
Table 111. Nelson Laboratories Company Details
Table 112. Nelson Laboratories Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 113. Nelson Laboratories Recent Development
Table 114. Pacific Biolabs Company Details
Table 115. Pacific Biolabs Business Overview
Table 116. Pacific Biolabs Product
Table 117. Pacific Biolabs Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 118. Pacific Biolabs Recent Development
Table 119. ATS Labs Company Details
Table 120. ATS Labs Business Overview
Table 121. ATS Labs Product
Table 122. ATS Labs Revenue in Bioburden Testing Business (2015-2020) (Million US$)
Table 123. ATS Labs Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bioburden Testing Market Share by Type: 2020 VS 2026
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Global Bioburden Testing Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical Case Studies
Figure 6. Biotechnology Case Studies
Figure 7. CMO Case Studies
Figure 8. Bioburden Testing Report Years Considered
Figure 9. Global Bioburden Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Bioburden Testing Market Share by Regions: 2020 VS 2026
Figure 11. Global Bioburden Testing Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Bioburden Testing Market Share by Players in 2019
Figure 14. Global Top Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioburden Testing as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Bioburden Testing Revenue in 2019
Figure 16. North America Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Bioburden Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
バイオモニタリング・バイオバーデン試験の世界市場（～2026年） Biomonitoring is a simple process its of two type, the very first one is to check the toxic level before and after the project is completed and the other one is the proper checking of all the valid regulation and parameter for the project and maintained the guideline. Bioburden are refer as the numb…- 生物製剤安全性試験の世界市場（～2026年） Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases. Market…
- NVHテストの世界市場（～2026年） The growth of the NVH testing market is propelled by the adoption of stringent government regulations to reduce noise pollution and increasing demand for automotive and car infotainment system. The NVH testing market in Europe is expected to register the highest CAGR between 2017 and 2023. Market An…
- 骨・ミネラル診断検査の世界市場（～2026年） Bone and mineral metabolism disorder is a collective term used to describe various conditions that make bones weak. Bone mineral metabolism maintains sufficient concentration of inorganic ions in blood serum. Progressive chronic kidney disease, especially end-stage renal disease (ESRD), is responsib…
- 遺伝子検査の世界市場（～2026年） Genetic testing, also known as DNA testing, allows the determination of bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. In agriculture, a form of genetic testing known as progeny testing can be used to evaluate the quality of breeding stock. In population ecology, gene…